Needham & Company
-
Stryker (SYK) PT Raised to $442 at Needham, added to Conviction List
-
Needham Upgrades Stryker (SYK) to Buy
-
Needham & Company Downgrades K2M Group Holdings (KTWO) to Hold
-
Needham & Company Upgrades Stryker (SYK) to Hold
-
Needham & Company Downgrades Stryker (SYK) to Underperform
-
ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company
-
Needham & Company Downgrades Stryker (SYK) to Hold
-
Needham & Company Raises Price Target on Stryker Corp. (SYK) Following 2Q15
-
Stryker (SYK) PT, Estimates Raised at Needham & Company Following 'Solid' Q1
-
Stryker (SYK) PT Bumped to $105 at Needham & Company
-
Needham & Company Issues Thoughts on Potential Stryker (SYK) Acquisition of Smith & Nephew (SNN); Raises PT to $101
-
Notable Mergers and Acquisitions of the Day 11/24: (RNR)/(PTP) (AMT)/(TSU) (HLS) (DDD)/(CIMT)
-
Needham & Company Upgrades Stryker (SYK) to Buy
-
Needham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
-
CONMED (CNMD) Worth up to $59/Share in Takeover - Needham & Company
-
Needham & Company Starts Stryker (SYK) at Hold
-
Notable Analyst Rating Changes 10/20: NIHD, MOS, JNPR, SYK Upgraded; AMLN, BAC, FSII, WDC Downgraded
-
Needham & Company Reiterates a 'Hold' on Stryker Corp. (SYK); Lowering Estimates On Reduced Market Growth Outlook
-
Needham Slashes Estimates on Stryker (SYK), Sees EPS and Revenue Miss in '09 On Deteriorating Fundamentals
-
Needham Downgrades Stryker Corp. (SYK) to Hold
-
Needham & Co's Top MedTech Picks: MDT, SYK, ISRG, NUVA
-
Needham Upgrades Stryker (SYK) to Buy

